Cargando…

Role of Branched-Chain Amino Acid Metabolism in Type 2 Diabetes, Obesity, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease

Branched-chain amino acids (BCAAs) include leucine, isoleucine, and valine. Mammalians cannot synthesize these amino acids de novo and must acquire them through their diet. High levels of BCAAs are associated with insulin resistance; type 2 diabetes; obesity; and non-metabolic diseases, including se...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuomo, Paola, Capparelli, Rosanna, Iannelli, Antonio, Iannelli, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030262/ https://www.ncbi.nlm.nih.gov/pubmed/35457142 http://dx.doi.org/10.3390/ijms23084325

Ejemplares similares

Microbiota–Liver Diseases Interactions
por: Capparelli, Rosanna, et al.
Publicado: (2023)

An In Vitro Model to Investigate the Role of Helicobacter Pylori in Type 2 Diabetes, Obesity, Alzheimer’s Disease and Cardiometabolic Disease
por: Cuomo, Paola, et al.
Publicado: (2020)

Gut Microbiota Host–Gene Interaction
por: Cuomo, Paola, et al.
Publicado: (2022)

Role of Epigenetics in Type 2 Diabetes and Obesity
por: Capparelli, Rosanna, et al.
Publicado: (2021)

Genetics of Host Protection against Helicobacter pylori Infections
por: Capparelli, Rosanna, et al.
Publicado: (2021)

Epigenetics and Helicobacter pylori
por: Capparelli, Rosanna, et al.
Publicado: (2022)

A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease
por: Goffredo, Martina, et al.
Publicado: (2017)

Bacteriophages Promote Metabolic Changes in Bacteria Biofilm
por: Papaianni, Marina, et al.
Publicado: (2020)

Bacteriophage-Resistant Salmonella rissen: An In Vitro Mitigated Inflammatory Response
por: Capparelli, Rosanna, et al.
Publicado: (2021)

Interaction between MyD88, TIRAP and IL1RL1 against Helicobacter pylori infection
por: Fulgione, Andrea, et al.
Publicado: (2020)

No association between binge eating disorder and severity of non‐alcoholic fatty liver disease in severely obese patients
por: Canivet, Clémence M, et al.
Publicado: (2020)

The hypothesis that Helicobacter pylori predisposes to Alzheimer’s disease is biologically plausible
por: Contaldi, Felice, et al.
Publicado: (2017)

Author Correction: The hypothesis that Helicobacter pylori predisposes to Alzheimer’s disease is biologically plausible
por: Contaldi, Felice, et al.
Publicado: (2018)

The Staphylococcus aureus Peptidoglycan Protects Mice against the Pathogen and Eradicates Experimentally Induced Infection
por: Capparelli, Rosanna, et al.
Publicado: (2011)

Non-Alcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: Role of Circulating Branched-Chain Amino Acids
por: van den Berg, Eline H., et al.
Publicado: (2019)

Aberrant branched-chain amino acid catabolism in cardiovascular diseases
por: Xiong, Yixiao, et al.
Publicado: (2022)

The Emerging Role of Branched-Chain Amino Acids in Liver Diseases
por: Lo, Emily Kwun Kwan, et al.
Publicado: (2022)

Synergistic Antibacterial and Anti-Inflammatory Activity of Temporin A and Modified Temporin B In Vivo
por: Capparelli, Rosanna, et al.
Publicado: (2009)

Assessment of Cardiovascular Parameters in Obese Children and Adolescents with Non-Alcoholic Fatty Liver Disease
por: Eklioğlu, Beray Selver, et al.
Publicado: (2015)

Coordinated Modulation of Energy Metabolism and Inflammation by Branched-Chain Amino Acids and Fatty Acids
por: Ye, Zhenhong, et al.
Publicado: (2020)

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Association of Circulating Branched-Chain Amino Acids with Cardiovascular Diseases: A Mendelian Randomization Study
por: Xu, Huan, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Impaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats
por: Anzai, Álvaro, et al.
Publicado: (2017)

Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
por: Lefere, Sander, et al.
Publicado: (2019)

Branched-chain amino acid metabolism in cancer
por: Ananieva, Elitsa A., et al.
Publicado: (2018)

Disorders of branched chain amino acid metabolism
por: Manoli, I., et al.
Publicado: (2016)

Branched Chain Amino Acids Are Associated with Physical Performance in Patients with End-Stage Liver Disease
por: Trillos-Almanza, Maria Camila, et al.
Publicado: (2023)

Serum branch-chained amino acids are increased in type 2 diabetes and associated with atherosclerotic cardiovascular disease
por: Moreno-Vedia, Juan, et al.
Publicado: (2023)

Modular pathway engineering for the microbial production of branched-chain fatty alcohols
por: Jiang, Wen, et al.
Publicado: (2017)

Recent Progress on Branched-Chain Amino Acids in Obesity, Diabetes, and Beyond
por: Siddik, Md Abu Bakkar, et al.
Publicado: (2019)

Branched-Chain Amino Acids and Branched-Chain Keto Acids in Hyperammonemic States: Metabolism and as Supplements
por: Holeček, Milan
Publicado: (2020)

Metabolism of cyclic GMP in non-alcoholic fatty liver disease in morbid obesity
por: Urios, Amparo, et al.
Publicado: (2011)

The association of lipid metabolism and non-alcoholic fatty liver disease in children with obesity
por: Hazer, İlhan, et al.
Publicado: (2020)

Branched chain amino acid transaminase 1 (BCAT1) is overexpressed and hypomethylated in patients with non-alcoholic fatty liver disease who experience adverse clinical events: A pilot study
por: Wegermann, Kara, et al.
Publicado: (2018)

Branched Chain Amino Acids: Beyond Nutrition Metabolism
por: Nie, Cunxi, et al.
Publicado: (2018)

Branched-chain amino acids are linked with iron metabolism
por: Enko, Dietmar, et al.
Publicado: (2020)

Branched-chain amino acids in health and disease: metabolism, alterations in blood plasma, and as supplements
por: Holeček, Milan
Publicado: (2018)

New Evidence of Oral Branched-Chain Amino Acid Supplementation on the Prognosis of Patients With Advanced Liver Disease
por: Lee, Hankil, et al.
Publicado: (2022)

Oral administration of branched-chain amino acids ameliorates high-fat diet-induced metabolic-associated fatty liver disease via gut microbiota-associated mechanisms
por: Zhang, Ranran, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qoh0orq1rqnufipqbk1hrkovqh